| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/25/2006 | EP1392241A4 System for osmotic delivery of pharmaceutically active agents |
| 01/25/2006 | EP1347965B1 New desloratadine salts, process for their synthesis and pharmaceutical compositions thereof |
| 01/25/2006 | EP1235825B1 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 01/25/2006 | EP1144650B1 Goodpasture antigen binding protein |
| 01/25/2006 | EP1115408B1 Oxihumic acid and its use in the treatment of various conditions |
| 01/25/2006 | CN1726283A Production of multimeric fusion proteins using a C4BP scaffold |
| 01/25/2006 | CN1726216A C-6 modified indazolylpyrrolotriazines |
| 01/25/2006 | CN1726023A Pregabalin and derivatives thereof for the treatment of fibromyalgia and other related disorders |
| 01/25/2006 | CN1726022A Pregabalin derivatives for the treatment of fibromyalgia and other disorders and its derivitive |
| 01/25/2006 | CN1726021A Alpha2delta ligands for the treatment of sexual dysfunction |
| 01/25/2006 | CN1726015A Alpha2delta ligands for different pharmaceutical uses |
| 01/25/2006 | CN1724571A New saponin and its derivative, its preparation method and its use in medicine |
| 01/25/2006 | CN1724066A Controlled release composition and method of producing the same |
| 01/25/2006 | CN1724056A Salmon roe nutrition and health-care soft capsule, and its prepn. process |
| 01/25/2006 | CN1723991A Method for preparing strengthening Yang and eliminating fatigue oral liquor contg. nanometer pilose antler and micron powder of semen juglandis, pine pollen and ants etc. |
| 01/25/2006 | CN1723986A Effervescent tablets contg. Astragalus root and fructus ligustric lucidi for strengthening the body resistance, and its prepn. art |
| 01/25/2006 | CN1723908A Gelatin micro-particles carried with dichloromethylene diphosphonate, and its prepn. method |
| 01/25/2006 | CN1723894A Dripping pills contg. (R)-3-[(S)-(5-oxyl-2-pyrrolidinyl)carbonyl]- thiazolidine-4-carboxyl, and its prepn. method |
| 01/25/2006 | CN1238367C Isolated nucleic acid molecules which encode T cell inducible factors (TIF), proteins encoded, and uses thereof |
| 01/25/2006 | CN1238354C Analog of nerve growth factor (2S, 4S)-2-(2'substituent)-4-(indole-3-methine)-5,5-disubstituent group-1, 3-f azole alkane compound, preparation method and application thereof |
| 01/25/2006 | CN1238341C 1 Alpha-hydroxy-25-ene-vitamin D, analogs and use thereof |
| 01/25/2006 | CN1237982C Cactus primary juice and its preparation method and application |
| 01/25/2006 | CN1237980C Anti virus health care product extracted from sea weed and its preparation method |
| 01/24/2006 | US6989435 Compounds and methods to inhibit or augment an inflammatory response |
| 01/24/2006 | US6989393 Ccr5 modulators benzimidazoles or benzotriazoles |
| 01/24/2006 | US6989389 Immunomodulators; tetrahydroimidazo[4,5-c]quinoline-4-amine-1-(alkynyloxyalkyl) derivatives; induce cytokines biosynthesis; antitumor agents, viral diseases |
| 01/24/2006 | US6989385 Pyrazole compounds useful as protein kinase inhibitors |
| 01/24/2006 | US6989372 medicaments intended to increase the intracellular and/or extracellular level of glutathione (GSH); for example, N-(N-Acetyl-L-cysteinyl)-S-acetylcysteamine; hiv treatment |
| 01/24/2006 | US6989270 Using polyamide nucleic acid oligomers to engender a biological response |
| 01/24/2006 | US6989260 Gene expression inhibition; for treatment of inflammatory, neurological, cardiovascular, and neoplastic tisssue growth disorders |
| 01/24/2006 | US6989255 for protection against staphylococcus infection; fusion proteins |
| 01/24/2006 | US6989159 Pharmaceutical compositions containing lithium carbonate |
| 01/24/2006 | US6989146 Stress proteins and peptides and methods of use thereof |
| 01/24/2006 | US6989145 Chimeric antibody for use in the diagnosis and treatment of blood cancer and immune defects |
| 01/24/2006 | CA2292984C Ccr5 modulators |
| 01/24/2006 | CA2100228C Phospholipid derivatives |
| 01/19/2006 | WO2006006741A1 Fused benzamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 01/19/2006 | WO2006006740A1 3-aminobenamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 01/19/2006 | WO2006006722A1 Method of controlling cell functions |
| 01/19/2006 | WO2006006720A1 METHOD OF CULTURING ϜδT CELLS, ϜδT CELLS AND REMEDY/PREVENTIVE |
| 01/19/2006 | WO2006006616A1 Method of evaluating evenness of suplatast tosilate crystal, even crystal, and process for producing the same |
| 01/19/2006 | WO2004094620A3 Truncated baff receptors |
| 01/19/2006 | US20060014948 e.g 1-[3,5-bis(trifluoromethyl)benzoyl]-2-[3-[(2-methoxyethoxy)-methoxy]-4-methylbenzyl]-4-[2-[(3R)-3-methoxymethyl-morpholino]ethyl]piperazine; treating or preventing Tachykinin-mediated diseases in humans or animals |
| 01/19/2006 | US20060014830 2-amino-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate and 2-(methylamino)-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate; fatty acid amide (FAAH) hyrdrolase inhibitors; analgesics; neuropathic pain;psychological disorders; anticarcinogenic agents; AIDS |
| 01/19/2006 | US20060014803 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 01/19/2006 | US20060014792 Heterocyclo inhibitors of potassium channel function |
| 01/19/2006 | US20060014787 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 01/19/2006 | US20060014780 Nicotinamide derivatives useful as PDE4 inhibitors |
| 01/19/2006 | US20060014747 Ortho-substituted anthranilic acid amides and their use as pharmaceutical agents |
| 01/19/2006 | US20060014736 Phenothiazine kinesin inhibitors |
| 01/19/2006 | US20060014735 immunoglobulins; affinity chromatography |
| 01/19/2006 | US20060014725 6-(1-benzyl-3-pentyl-1H-indol-2-yl)-1-bromo-2-naphthyl 1H-tetraazol-5-ylmethyl ether; useful in treating stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders |
| 01/19/2006 | US20060014701 Novel amide derivatives as growth hormone secretagogues |
| 01/19/2006 | US20060014672 Tumor specific oligosaccharide epitopes and use thereof |
| 01/19/2006 | US20060014276 Chimeric adenoviruses |
| 01/19/2006 | US20060014243 Human G-protein chemokine receptor HSATU68 |
| 01/19/2006 | US20060014139 Which comprises three N-helices and at least two, but not three, of the three C-helices of the trimer-of-hairpin structure of HIV gp41; inhibits infection of cells; drug screening; gene therapy |
| 01/19/2006 | US20060013902 Pharmaceutical products for treating neoplastic disease and inflammation |
| 01/19/2006 | US20060013869 Electrospun amorphous pharmaceutical compositions |
| 01/19/2006 | US20060013811 Methods of treating IgE-associated disorders and compositions for use therein |
| 01/19/2006 | DE102004063363A1 Composition for treatment and prevention of bronchial disease or allergy and for strengthening immune system, contains capsaicin or its derivatives |
| 01/19/2006 | CA2573481A1 Method of evaluating evenness of suplatast tosilate crystal, even crystal, and process for producing the same |
| 01/18/2006 | EP1617219A1 Element having bioactive substance fixed thereto |
| 01/18/2006 | EP1617218A1 METHOD OF SCREENING DRUG WITH THE USE OF 67 kDa LAMININ RECEPTOR AND DRUG OBTAINED THEREBY |
| 01/18/2006 | EP1617216A1 Novel method of screening |
| 01/18/2006 | EP1616958A2 Notch-ligands for use in immunotherapy |
| 01/18/2006 | EP1616954A2 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 01/18/2006 | EP1616878A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/18/2006 | EP1616866A1 M-stage kinesin inhibitor |
| 01/18/2006 | EP1616862A1 Nitrogenous heterocyclic compound and use thereof |
| 01/18/2006 | EP1616861A2 A process for the preparation of keto compounds |
| 01/18/2006 | EP1616578A1 Compositions and methods for delivery of genetic material |
| 01/18/2006 | EP1616574A1 Receptor specific transepithelial transport of therapeutics |
| 01/18/2006 | EP1616573A2 Adjuvants for use in vaccines |
| 01/18/2006 | EP1615898A1 2-aminopyrimidine derivatives and their medical use |
| 01/18/2006 | EP1615664A1 Pharmaceutical composition for treatment of immunological disorders |
| 01/18/2006 | EP1615659A2 Use of bv8 and/or eg-vegf to promote hematopoiesis |
| 01/18/2006 | EP1615657A1 Immunomodulatory product obtained from a bifidobacterium culture and compositions containing the same |
| 01/18/2006 | EP1615656A2 Immunomodulatory product obtained from a bifidobacterium culture and compositions containing the same |
| 01/18/2006 | EP1615655A1 Compositions for mucosal and oral administration comprising hcg fragments |
| 01/18/2006 | EP1501505B1 Use of (3-(2-ethylphenyl)-5-methoxyphenyl)-1h- 1,2,4 -triazole for the treatment of autoimmune diseases |
| 01/18/2006 | EP1463799A4 Methods for the induction of professional and cytokine-producing regulatory cells |
| 01/18/2006 | EP1412338B1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| 01/18/2006 | EP1392309A4 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 01/18/2006 | EP1268096B1 Extrusion die |
| 01/18/2006 | EP1220852B1 Substituted diazepans |
| 01/18/2006 | EP1210327B1 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 01/18/2006 | CN1723210A Fused furan compound |
| 01/18/2006 | CN1723196A Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/18/2006 | CN1723193A Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/18/2006 | CN1723030A Remedies or preventing for allergic diseases comprising processed peanut seed coat |
| 01/18/2006 | CN1723013A Use of estrogen receptor alpha modulators for the treatment of multiple sclerosis |
| 01/18/2006 | CN1721447A Modified peptides as therapeutic agents |
| 01/18/2006 | CN1721443A Human receptor proteins, related reagents and methods |
| 01/18/2006 | CN1721442A Proteins producing an altered immunogenic response and methods of making and using the same |
| 01/18/2006 | CN1721412A 7-oxo pyridopyrimidines |
| 01/18/2006 | CN1721411A Benzimidazole derivatives as modulators IgE |
| 01/18/2006 | CN1721401A Inhibitors of LFA-1 binding to ICAMS and uses thereof |
| 01/18/2006 | CN1720998A Preparation and application of pig interleukin-2 gene anti-infectious preparation |
| 01/18/2006 | CN1720985A Erythromelalgia treating medicine |